Justin Leong's most recent trade in Resmed Inc. was a trade of 1,848 ReMed Common Stock done . Disclosure was reported to the exchange on Nov. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ResMed | Justin Leong | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 1,848 | 29,028 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 5,462 | 27,180 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 243.09 per share. | 22 Nov 2024 | 6,160 | 21,718 (0%) | 0% | 243.1 | 1,497,416 | ReMed Common Stock |
| ResMed | Justin Leong | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 8,259 | 27,000 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 878 | 27,878 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | President, Asia Latin America | Sale of securities on an exchange or to another person at price $ 217.07 per share. | 05 Aug 2024 | 48,000 | 18,741 (0%) | 0% | 217.1 | 10,419,552 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2022 | 15,000 | 0 | - | - | ResMed Common Stock Options | |
| ResMed | Justin Leong | President, Asia Latin America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 22 Nov 2022 | 15,000 | 63,594 (0%) | 0% | 57.8 | 866,400 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2022 | 6,924 | 66,741 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | President, Asia Latin America | Sale of securities on an exchange or to another person at price $ 229.50 per share. | 22 Nov 2022 | 3,777 | 59,817 (0%) | 0% | 229.5 | 866,820 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2022 | 9,973 | 9,973 | - | - | ResMed Common Stock Options | |
| ResMed | Justin Leong | President, Asia Latin America | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.81 per share. | 24 Nov 2021 | 1,339 | 48,391 (0%) | 0% | 254.8 | 341,191 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia and LATAM | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2021 | 8,134 | 8,134 | - | - | ResMed Common Stock Options | |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 254.81 per share. | 16 Nov 2021 | 9,162 | 49,857 (0%) | 0% | 254.8 | 2,334,569 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 254.81 per share. | 16 Nov 2021 | 9,162 | 49,857 (0%) | 0% | 254.8 | 2,334,569 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.81 per share. | 16 Nov 2021 | 765 | 49,092 (0%) | 0% | 254.8 | 194,930 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 638 | 49,730 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 638 | 49,933 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Justin Leong | President, Asia Latin America | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.47 per share. | 16 Nov 2021 | 562 | 49,295 (0%) | 0% | 259.5 | 145,822 | ReMed Common Stock |
| ResMed | Justin Leong | President, Asia Latin America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 2,631 | 40,695 (0%) | 0% | 0 | ReMed Common Stock |